The anti-fibrogenic effect of a pharmaceutical composition of [5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione] (oltipraz) and dimethyl-4,4′-dimethoxy-5,6,5′,6′-dimethylene dioxybiphenyl-2,2′-dicarboxylate (DDB)

Archives of Pharmacal Research

Volumn 25, Issue 5, 2002, Pages 655-663

  Keon, Wook Kang ^a   Yoon, Gyoon Kim ^a   Choon, Won Kim ^b   Sang, Geon Kim ^a  

^a Seoul National University   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

DDB; Dimethylnitrosamine; Fibrosis; Oltipraz; Pharmaceutical composition

Indexed keywords

CHLORINATED HYDROCARBON; DDB; DRUG; OLTIPRAZ; PYRAZINE DERIVATIVE;

ANIMAL; ARTICLE; CHEMISTRY; DRUG COMBINATION; LIVER CIRRHOSIS; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; DRUG COMBINATIONS; HYDROCARBONS, CHLORINATED; LIVER CIRRHOSIS; PHARMACEUTICAL PREPARATIONS; PYRAZINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0036780799     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/bf02976940     Document Type: Article

References (32)

1. Ansher, S. S., Dolan, P., and Bueding, E., Chemoprotective effects of two dithiolthiones and of butylhydroxyanisole against carbon tetrachloride and acetaminophen toxicity. Hepatology, 3, 932-935 (1983).
2. Bolton, M.G., Munoz, A., Jacobson, L. P., Groopman, J. D., Maxuitenko, Y. Y., and Roebuck, B. D., Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis. Cancer Res., 53, 3499-3504 (1993).
3. Bueding, E., Dolan, P., and Leroy, J.P., The antischistosomal activity of oltipraz. Res. Commun. Chem. Pathol. Pharmacol., 37, 293-303 (1982).
4. Clapper, M. L., Everley, L. C., Strobel, L. A., Townsend, A. J., and Engstrom, P. F., Coordinate induction of glutathione S-transferase α, μ, and π expression in murine liver after a single administration of oltipraz. Mol. Pharmacol., 45, 469-474 (1994).
5. Davidson, N. E., Patricia, A. E., and Kensler, T. W., Transcriptional control of glutathione S-transferase gene expression by the chemoprotective agent 5-(2-pyrazinyl)-1,2-dithione (oltipraz) in rat liver. Cancer Res., 50, 2251-2255 (1990).
6. George, J. and Chandrakasan, G., Molecular characteristics of dimethylnitrosamine-induced fibrotic liver collagen. Biochim. Biophys. Acta., 1292, 215-222 (1996).
7. Igarashi, S., Hatahara, T., Nagai, Y., Hori, H., Sakakibara, K., Katoh, M., Sakai, A., and Sugimoto, T., Anti-fibrotic effect of malotilate on liver fibrosis induced by carbon tetrachloride in rats. Jpn. J. Exp. Med., 56, 235-45 (1986).
8. Kang, K. W., Choi, S. H., Ha, J. R., Kim, C. W., and Kim, S. G., Inhibition of dimethylnitrosamine-induced liver fibrosis by [5-(2-pyrazinyl)-4- methyl-1,2-dithiol-3-thione] (oltipraz) in rats: suppression of transforming growth factor-beta1 and tumor necrosis factor-alpha expression. Chem. Biol. Interact., 139, 61-77 (2002).
9. Kensler, T. W., Egner, P. A., Dolan, P. M., Groopman, J. D., and Roebuck, B. D., Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Cancer Res., 47, 4271-4277 (1987).
10. Kim, J. H., Ahn, Y. K., and Ohsawa, M., Enhancing effects of diphenyl dimethyl dicarboxylate on serum antibody production in Balb/c mice. Biol. Pharm. Bull., 18, 24-27 (1995).
11. Kim, J. Y., Baek, M., Lee, S., Kim, S. O., Dong, M. S., Kim, B. R., and Kim, D. H., Characterization of the selectivity and mechanism of cytochrome P450 inhibition by dimethyl-4,4′-dimethoxy-5,6,5′,6′- dimethylenedioxybiphenyl-2,2′-dicarboxylate. Drug Metab. Dispos., 29, 1555-1560 (2001).
12. Kim, S. G., Nam, S. Y., Chung, H. C., Hong, S. Y., Jung, K. H., Enhanced effectiveness of dimethyl-4,4′-dimethoxy-5,6,5′,6′-dimethylene dioxybiphenyl-2,2′-dicarboxylate in combination with garlic oil against experimental hepatic injury in rats and mice. J. Pharm. Pharmacol., 47, 678-682 (1995).
13. Kim, S. G., Nam, S. Y., and Kim, C.W., In vivo radioprotective effects of oltipraz in g-irradiated mice, Biochem. Pharmacol., 55, 1585-1590 (1998).
14. Kim, S. G., Nam, S. Y., Kim, C. W., Kim, J. H., Cho, C. K., and Yoo, S. Y., Enhancement of radiation-inducible hepatic glutathione S-transferase gene by oltipraz: possible role in radioprotection, Mol. Pharmacol., 51, 225-233 (1997).
15. Kim, S. G., Kim, H. J., Choi, S. H., and Ryu, J. Y., Inhibition of lipopolysaccharide-induced I-kappaB degradation and tumor necrosis factor-alpha expression by dimethyl-4,4′-dimethoxy-5,6,5′,6′-dimethylene dioxybiphenyl-2,2′-dicarboxylate (DDB): minor role in hepatic detoxifying enzyme expression. Liver, 20, 319-329 (2000).
16. Kim, S. G., Kwak, J. Y., Lee, J. W., Novak, R. F., Park, S. S., and Kim, N. D., Malotilate, a hepatoprotectant, suppresses CYP2E1 expression in rats. Biochem. Biophys. Res. Commun., 200, 1414-1420 (1994).
17. Kondo, A., Ishikawa, O., Okada, K., Miyachi, Y., Abe, S., and Kuboki, Y., Measurement of histidinohydroxylysinonorleucine and hydroxyproline in skin collagen by reversed-phase high-performance liquid chromatography after 9-fluorenylmethyl chloroformate labeling. Anal. Biochem., 252, 255-259 (1997).
18. Kremer, J. M., Lee, R. G., and Tolman, K. G., Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples. Arthritis Rheum., 32, 121-127 (1989).
19. Lee, H. S., Kim, Y. T., and Jung, H. C., Prospective randomized controlled trial with diphenyldimethyldicarboxylate in chronic active liver disease: the effect on lowering serum alanine aminotransferase levels. Korean J. Int. Med., 40, 173-178 (1991).
20. Liu, K. T., and Lesca, P., Pharmacological properties of dibenz(a,o)cyclooctene derivatives isolated from Fructus schizandrae chinencis III. Inhibitory effects on carbon tetrachloride-induced lipid peroxidation, metabolism and covalent binding of carbon tetrachloride to lipids. Chem. Biol. Interact., 41, 39-47 (1982).
21. Manna, S. K., Mukhopadhyay, A., Van, N. T., and Aggarwal, B.B., Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis. J. Immunol., 163, 6800-6809 (1999).
22. Mansuy, D., Sassi, A., Dansette, P. M., and Plat, M., A new potent inhibitor of lipid peroxidation in vitro and in vivo, the hepatoprotective drug anisyldithiolthione. Biochem. Biophys. Res. Commun., 135, 1015-1021 (1986).
23. Maxuitenko, Y. Y., Libby, A. H., Joyner, H. H., Curphey, T. J., Macmillan, D. L., and Kensler, T. W., Identification of dithiolthione with better chemopreventive properties than oltipraz. Carcinogenesis, 19, 1609-1615 (1998).
24. Moragas, A., Allende, H., and Sans, M., Characteristics of perisinusoidal collagenization in liver cirrhosis: computer-assisted quantitative analysis. Anal. Quant. Cytol. Histol., 20, 169-177 (1998).
25. Okuno, H., Murase, T., Nakanishi, S., Shiozaki, Y., and Sameshima, Y., Effect of malotilate (diisopropyl 1,3-dithiol-2-ylidenemalonate) on drug metabolizing activity in rat liver microsomes. Jpn. J. Pharmacol., 44, 303-310 (1987).
26. Pares, A., Caballeria, L., Rodes, J., Bruguera, M., Rodrigo, L., Garcia-Plaza, A., Berenguer, J., Rodriguez-Martinez, D., Mercader, J., and Velicia, R., Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. J. Hepatol., 32, 561-566 (2000).
27. Pendyala, L., Schwartz, G., Bolanowska-Higdon, W., Hitt, S., Zdanowicz, J., Murphy, M., Lawrence, D., and Creaven, P. J., Phase I/pharmacodynamic study of N-acetylcysteine/oltipraz in smokers: early termination due to excessive toxicity. Cancer Epidemiol. Biomarkers Prev., 10, 269-272 (2001).
28. Shear, N. H., Malkiewicz, I. M., Klein, D., Koren, G., Randor, S., and Neuman, M. G., Acetaminophen-induced toxicity to human epidermoid cell line A431 and hepatoblastoma cell line Hep G2, in vitro, is diminished by silymarin. Skin Pharmacol., 8, 279-291 (1995).
29. Shimizu, I., Ma, Y. R., Mizobuchi, Y., Liu, F., Miura, T., Nakai, Y., Yasuda, M., Shiba, M., Horie, T., Amagaya, S., Kawada, N., Hori, H., and Ito, S., Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats. Hepatology, 29, 149-160 (1999).
30. Stohs, S. J., Lawson, T. A., Anderson, L., and Bueding, E., Effects of oltipraz, BHA, ADT and cabbage on glutathione metabolism, DNA damage and lipid peroxidation in old mice. Mech. Ageing Dev., 37, 137-145 (1986).
31. Tsukamoto, H., Matsuoka, M., and French, S. W., Experimental models of hepatic fibrosis: a review. Semin. Liv. Dis., 10, 56-63 (1990).
32. Zhang, B. C., Zhu, Y. R., Wang, J. B., Wu, Y., Zhang, Q. N., Qian, G. S., Kuang, S. Y., Li, Y. F., Fang, X., Yu, L. Y., De Flora, S., Jacobson, L. P., Zarba, A., Egner, P. A., He, X., Wang, J. S., Chen, B., Enger, C. L., Davidson, N. E., Gordon, G. B., Gorman, M. B., Prochaska, H. J., Groopman, J. D., Munoz, A., and Kensler, T. W., Oltipraz chemoprevention trial in Qidong, Jiangsu Province, People's Republic of China. J. Cell Biochem. Suppl., 28-29, 166-173 (1997).